The market is segmented based on Global Capillary Blood Collection and Sampling Devices Market, Product (Blood Sampling Devices, Capillary Blood Collection Devices, Rapid Test Cassette, Remote Capillary Blood Collection Device, Wearable Capillary Blood Collection Device), Modality (Manual Sampling, Automated/Autoinjection Sampling), Mode of Administration (Puncture, Incision), Application (Cardiovascular Disease, Infection and Infectious Disease, Respiratory Diseases, Cancers, Rheumatoid Arthritis, Others), Platform (Enzyme Immunoassay Platform (Elisa Platform), PCR Platform, Lateral Flow Immunoassay Platform, ELTABA Platform, Others), Procedure (Conventional, Point of Care Testing), Age Group (Geriatrics, Infant, Pediatric, Adult), Test Type (Whole Blood Test, Dried Blood Spot Tests, Plasma/Serum Protein Tests, Liver Panel/Liver Profile/Liver Function Tests, Comprehensive Metabolic Panel (CMP) Tests, Others), Technology (Volumetric Absorptive Microsampling, Capillary Electrophoresis-Based Chemical Analysis, Others), Material (Plastic, Glass, Stainless Steel, Ceramic), End User (Laboratories, Home Care Setting), Distribution Channel (Direct Tender, Retail Sales, Others) – Industry Trends and Forecast to 2030.
.
The Global Capillary Blood Collection And Sampling Devices Market size was valued at USD 2539.66 USD Billion in 2022.
The Global Capillary Blood Collection And Sampling Devices Market is projected to grow at a CAGR of 4.55% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.